Skip to main content
Top
Published in: BMC Pediatrics 1/2023

Open Access 01-12-2023 | Hip Dysplasia | Study protocol

Active monitoring versus an abduction device for treatment of infants with centered dysplastic hips: study protocol for a randomized controlled trial (TReatment with Active Monitoring (TRAM)-Trial)

Authors: Frederike E. C. M. Mulder, M. Adhiambo Witlox, Carmen D. Dirksen, Pieter Bas de Witte, Suzanne de Vos-Jakobs, Arno M. ten Ham, Melinda M. E. H. Witbreuk, Ralph Sakkers, Magritha (Margret) M. H. P. Foreman-van Drongelen, Simon G. F. Robben, Nina M. C. Mathijssen, TRAM-Trial Consortium

Published in: BMC Pediatrics | Issue 1/2023

Login to get access

Abstract

Background

Developmental Dysplasia of the Hip (DDH) is one of the most common pediatric orthopedic disorders, affecting 1–3% of all newborns. The optimal treatment of centered DDH is currently under debate. This randomized controlled trial aims to study the (cost-)effectiveness of active monitoring versus abduction treatment for infants with centered DDH.

Methods

This is a multicenter, parallel-group, open-label, non-inferiority randomized controlled trial studying the (cost-)effectiveness of active monitoring versus abduction treatment for infants with centered DDH in fourteen hospitals in the Netherlands. In total, 800 infants with centered DDH (Graf IIa-/IIb/IIc), aged 10–16 weeks, will be randomly allocated to the active monitoring or abduction treatment group. Infants will be followed up until the age of 24 months. The primary outcome is the rate of normal hips, defined as an acetabular index lower than 25 degrees on an antero-posterior radiograph, at the age of 12 months. Secondary outcomes are the rate of normal hips at the age of 24 months, complications, time to hip normalization, the relation between baseline patient characteristics and the rate of normal hips, compliance, costs, cost-effectiveness, budget impact, health-related quality of life (HRQoL) of the infant, HRQoL of the parents/caregivers, and parent/caregiver satisfaction with the treatment protocol.

Discussion

The outcomes of this randomized controlled trial will contribute to improving current care-as-usual for infants with centered DDH.

Trial registration

Dutch Trial Register, NL9714, registered September 6, 2021. https://​clinicaltrialreg​ister.​nl/​en/​trial/​29596
Literature
1.
go back to reference Schaeffer EK, Study Group I, Mulpuri K. Developmental dysplasia of the hip: addressing evidence gaps with a multicentre prospective international study. Med J Aust. 2018;208(8):359–64.CrossRefPubMed Schaeffer EK, Study Group I, Mulpuri K. Developmental dysplasia of the hip: addressing evidence gaps with a multicentre prospective international study. Med J Aust. 2018;208(8):359–64.CrossRefPubMed
2.
go back to reference Pollet V, Percy V, Prior HJ. Relative risk and incidence for developmental dysplasia of the hip. J Pediatr. 2017;181:202–7.CrossRefPubMed Pollet V, Percy V, Prior HJ. Relative risk and incidence for developmental dysplasia of the hip. J Pediatr. 2017;181:202–7.CrossRefPubMed
3.
go back to reference Kilsdonk I, Witbreuk M, Van Der Woude HJ. Ultrasound of the neonatal hip as a screening tool for DDH: how to screen and differences in screening programs between European countries. J Ultrason. 2021;21(85):e147–53.CrossRefPubMedPubMedCentral Kilsdonk I, Witbreuk M, Van Der Woude HJ. Ultrasound of the neonatal hip as a screening tool for DDH: how to screen and differences in screening programs between European countries. J Ultrason. 2021;21(85):e147–53.CrossRefPubMedPubMedCentral
4.
go back to reference Engesæter I, Lehmann T, Laborie LB, Lie SA, Rosendahl K, Engesæter LB. Total hip replacement in young adults with hip dysplasia: age at diagnosis, previous treatment, quality of life, and validation of diagnoses reported to the Norwegian Arthroplasty Register between 1987 and 2007. Acta Orthop. 2011;82(2):149–54.CrossRefPubMedPubMedCentral Engesæter I, Lehmann T, Laborie LB, Lie SA, Rosendahl K, Engesæter LB. Total hip replacement in young adults with hip dysplasia: age at diagnosis, previous treatment, quality of life, and validation of diagnoses reported to the Norwegian Arthroplasty Register between 1987 and 2007. Acta Orthop. 2011;82(2):149–54.CrossRefPubMedPubMedCentral
5.
go back to reference Graf R. Classification of hip joint dysplasia by means of sonography. Arch Orthop Trauma Surg. 1984;102(4):248–55.CrossRefPubMed Graf R. Classification of hip joint dysplasia by means of sonography. Arch Orthop Trauma Surg. 1984;102(4):248–55.CrossRefPubMed
6.
go back to reference Theunissen W, van der Steen M, van Douveren F, Witlox AMA, Tolk JJ. Timing of repeat ultrasound examination in treatment of stable developmental dysplasia of the hip. J Pediatr Orthop. 2021;41(4):203–8.CrossRefPubMedPubMedCentral Theunissen W, van der Steen M, van Douveren F, Witlox AMA, Tolk JJ. Timing of repeat ultrasound examination in treatment of stable developmental dysplasia of the hip. J Pediatr Orthop. 2021;41(4):203–8.CrossRefPubMedPubMedCentral
7.
go back to reference Roovers EA, Boere-Boonekamp MM, Mostert AK, Castelein RM, Zielhuis GA, Kerkhoff TH. The natural history of developmental dysplasia of the hip: sonographic findings in infants of 1–3 months of age. J Pediatr Orthop B. 2005;14(5):325–30.CrossRefPubMed Roovers EA, Boere-Boonekamp MM, Mostert AK, Castelein RM, Zielhuis GA, Kerkhoff TH. The natural history of developmental dysplasia of the hip: sonographic findings in infants of 1–3 months of age. J Pediatr Orthop B. 2005;14(5):325–30.CrossRefPubMed
8.
go back to reference Sakkers R, Pollet V. The natural history of abnormal ultrasound findings in hips of infants under six months of age. J Child Orthop. 2018;12(4):302–7.CrossRefPubMedPubMedCentral Sakkers R, Pollet V. The natural history of abnormal ultrasound findings in hips of infants under six months of age. J Child Orthop. 2018;12(4):302–7.CrossRefPubMedPubMedCentral
9.
go back to reference Graf R. Hip sonography. Diagnosis and management of infant hip dysplasia. 2nd ed. Berlin: Springer; 2006. Graf R. Hip sonography. Diagnosis and management of infant hip dysplasia. 2nd ed. Berlin: Springer; 2006.
10.
go back to reference Pollet V, Castelein RM, van de Sande M, Witbreuk M, Mostert AK, Besselaar A, et al. Abduction treatment in stable hip dysplasia does not alter the acetabular growth: results of a randomized clinical trial. Sci Rep. 2020;10(1):9647.CrossRefPubMedPubMedCentral Pollet V, Castelein RM, van de Sande M, Witbreuk M, Mostert AK, Besselaar A, et al. Abduction treatment in stable hip dysplasia does not alter the acetabular growth: results of a randomized clinical trial. Sci Rep. 2020;10(1):9647.CrossRefPubMedPubMedCentral
11.
go back to reference Wood MK, Conboy V, Benson MK. Does early treatment by abduction splintage improve the development of dysplastic but stable neonatal hips? J Pediatr Orthop. 2000;20(3):302–5.CrossRefPubMed Wood MK, Conboy V, Benson MK. Does early treatment by abduction splintage improve the development of dysplastic but stable neonatal hips? J Pediatr Orthop. 2000;20(3):302–5.CrossRefPubMed
12.
go back to reference Rosendahl K, Dezateux C, Fosse KR, Aase H, Aukland SM, Reigstad H, et al. Immediate treatment versus sonographic surveillance for mild hip dysplasia in newborns. Pediatrics. 2010;125(1):e9-16.CrossRefPubMed Rosendahl K, Dezateux C, Fosse KR, Aase H, Aukland SM, Reigstad H, et al. Immediate treatment versus sonographic surveillance for mild hip dysplasia in newborns. Pediatrics. 2010;125(1):e9-16.CrossRefPubMed
13.
go back to reference Brurås KR, Aukland SM, Markestad T, Sera F, Dezateux C, Rosendahl K. Newborns with sonographically dysplastic and potentially unstable hips: 6-year follow-up of an RCT. Pediatrics. 2011;127(3):e661–6.CrossRefPubMed Brurås KR, Aukland SM, Markestad T, Sera F, Dezateux C, Rosendahl K. Newborns with sonographically dysplastic and potentially unstable hips: 6-year follow-up of an RCT. Pediatrics. 2011;127(3):e661–6.CrossRefPubMed
14.
go back to reference Sucato DJ, Johnston CE 2nd, Birch JG, Herring JA, Mack P. Outcome of ultrasonographic hip abnormalities in clinically stable hips. J Pediatr Orthop. 1999;19(6):754–9.CrossRefPubMed Sucato DJ, Johnston CE 2nd, Birch JG, Herring JA, Mack P. Outcome of ultrasonographic hip abnormalities in clinically stable hips. J Pediatr Orthop. 1999;19(6):754–9.CrossRefPubMed
15.
go back to reference Kim HKW, Beckwith T, De La Rocha A, Zepeda E, Jo CH, Sucato D. Treatment patterns and outcomes of stable hips in infants with ultrasonic dysplasia. J Am Acad Orthop Surg. 2019;27(2):68–74.CrossRefPubMed Kim HKW, Beckwith T, De La Rocha A, Zepeda E, Jo CH, Sucato D. Treatment patterns and outcomes of stable hips in infants with ultrasonic dysplasia. J Am Acad Orthop Surg. 2019;27(2):68–74.CrossRefPubMed
16.
go back to reference Paulussen EMB, Mulder F, Mathijssen NMC, Witlox MA. Active monitoring versus immediate abduction as treatment of stable developmental dysplasia of the hip: a systematic review of the literature. BMJ Open. 2022;12(9):e057906.CrossRefPubMedPubMedCentral Paulussen EMB, Mulder F, Mathijssen NMC, Witlox MA. Active monitoring versus immediate abduction as treatment of stable developmental dysplasia of the hip: a systematic review of the literature. BMJ Open. 2022;12(9):e057906.CrossRefPubMedPubMedCentral
17.
go back to reference van Bergen CJA, de Witte PB, Willeboordse F, de Geest BL, Foreman-van Drongelen M, Burger BJ, et al. Treatment of centered developmental dysplasia of the hip under the age of 1 year: an evidence-based clinical practice guideline - Part 1. EFORT Open Rev. 2022;7(7):498–505.CrossRefPubMedPubMedCentral van Bergen CJA, de Witte PB, Willeboordse F, de Geest BL, Foreman-van Drongelen M, Burger BJ, et al. Treatment of centered developmental dysplasia of the hip under the age of 1 year: an evidence-based clinical practice guideline - Part 1. EFORT Open Rev. 2022;7(7):498–505.CrossRefPubMedPubMedCentral
18.
go back to reference Ömeroğlu H, Köse N, Akceylan A. Success of Pavlik harness treatment decreases in patients ≥ 4 months and in ultrasonographically dislocated hips in developmental dysplasia of the hip. Clin Orthop Relat Res. 2016;474(5):1146–52.CrossRefPubMed Ömeroğlu H, Köse N, Akceylan A. Success of Pavlik harness treatment decreases in patients ≥ 4 months and in ultrasonographically dislocated hips in developmental dysplasia of the hip. Clin Orthop Relat Res. 2016;474(5):1146–52.CrossRefPubMed
19.
go back to reference Hakkaart-van Roijen L, van der Linden N, Bouwmans C, Kanters T, Swan Tan S. Kostenhandleiding: Methodologie van kostenonderzoek en referentieprijzen voor economische evaluaties in de gezondheidszorg. 2016. Hakkaart-van Roijen L, van der Linden N, Bouwmans C, Kanters T, Swan Tan S. Kostenhandleiding: Methodologie van kostenonderzoek en referentieprijzen voor economische evaluaties in de gezondheidszorg. 2016.
20.
go back to reference Mauskopf JA, Sullivan SD, Annemans L, Caro J, Mullins CD, Nuijten M, et al. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices–budget impact analysis. Value Health. 2007;10(5):336–47.CrossRefPubMed Mauskopf JA, Sullivan SD, Annemans L, Caro J, Mullins CD, Nuijten M, et al. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices–budget impact analysis. Value Health. 2007;10(5):336–47.CrossRefPubMed
Metadata
Title
Active monitoring versus an abduction device for treatment of infants with centered dysplastic hips: study protocol for a randomized controlled trial (TReatment with Active Monitoring (TRAM)-Trial)
Authors
Frederike E. C. M. Mulder
M. Adhiambo Witlox
Carmen D. Dirksen
Pieter Bas de Witte
Suzanne de Vos-Jakobs
Arno M. ten Ham
Melinda M. E. H. Witbreuk
Ralph Sakkers
Magritha (Margret) M. H. P. Foreman-van Drongelen
Simon G. F. Robben
Nina M. C. Mathijssen
TRAM-Trial Consortium
Publication date
01-12-2023
Publisher
BioMed Central
Keyword
Hip Dysplasia
Published in
BMC Pediatrics / Issue 1/2023
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-023-04012-2

Other articles of this Issue 1/2023

BMC Pediatrics 1/2023 Go to the issue